Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome”

Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low... Hindawi Case Reports in Immunology Volume 2021, Article ID 2361360, 1 page https://doi.org/10.1155/2021/2361360 Erratum Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome” 1 2 Cesar Daniel Alonso-Bello , Marı´a del Carmen Jime´nez-Martı´nez , 1 3 Marı´a Eugenia Vargas-Camaño, Sagrario Hierro-Orozco, 4 5 6 Mario Alberto Ynga-Durand , Laura Berro´n-Ruiz, Julio Ce´sar Alca´ntara-Montiel, 6 1 1 Leopoldo Santos-Argumedo, Diana Andrea Herrera-Sa´nchez, Fernando Lozano-Patiño, and Marı´a Isabel Castrejo´n-Va´zquez Immunology and Allergy Department, Centro M´edico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico Faculty of Medicine, Universidad Nacional Auto´noma de M´exico, Mexico City, Mexico Dermatology Department, Centro M´edico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico Laboratorio de Inmunidad de Mucosas, Seccio´n de Investigacio´n y Posgrado, Escuela Superior de Medicina, Instituto Polit´ecnico Nacional, Mexico City, Mexico Immunodeficiencies Research Unit, Instituto Nacional de Pediatria, Secretar´ıa de Salud, Mexico City, Mexico Department of Molecular Biomedicine, CINVESTAV-IPN, Mexico City, Mexico Correspondence should be addressed to Cesar Daniel Alonso-Bello; cesar_alonso86@hotmail.com Received 27 October 2020; Accepted 27 October 2020; Published 12 February 2021 Copyright © 2021 Cesar Daniel Alonso-Bello et al. &is is an open access article distributed under the Creative Commons AttributionLicense, which permitsunrestricteduse, distribution, andreproductioninanymedium, providedthe originalworkis properly cited. In the article titled “Partial and Transient Clinical Response &e corrected list of affiliations is shown in the authors’ to Omalizumab in IL-21-Induced Low STAT3-Phosphor- information above. ylation on Hyper-IgE Syndrome” [1], authors Mario Alberto Ynga-Durand and Julio Ce´sar Alca´ntara-Montiel References were affiliated to “Universidad Nacional Auto´noma de [1] C. D. Alonso-Bello, M. d. C. Jimenez-Mart ´ ´ınez, M. E. Vargas- Mexico, Facultad de Estudios Superiores Zaragoza, Fac- Camaño et al., “Partial and Transient Clinical Response to ultad de Medicina, Mexico,” which is incorrect. Omalizumab in IL-21-Induced Low STAT3-Phosphorylation &e correct affiliation of Mario Alberto Ynga-Durand is on Hyper-IgE Syndrome,” Case Reports in Immunology, “Laboratorio de Inmunidad de Mucosas, Seccion de Inves- vol. 2019, Article ID 6357256, 5 pages, 2019. tigacio´n y Posgrado, Escuela Superior de Medicina, Instituto Polite´cnico Nacional, Mexico City, Mexico.” &e correct af- filiation for Julio Ce´sar Alca´ntara-Montiel is “Department of Molecular Biomedicine, CINVESTAV-IPN, Mexico City, Mexico.” &e error was introduced during the production process of the article, and Hindawi apologises for causing this error in the article. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Case Reports in Immunology Hindawi Publishing Corporation

Loading next page...
 
/lp/hindawi-publishing-corporation/erratum-to-partial-and-transient-clinical-response-to-omalizumab-in-il-UV7W02XSDV
Publisher
Hindawi Publishing Corporation
Copyright
Copyright © 2021 Cesar Daniel Alonso-Bello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
ISSN
2090-6609
eISSN
2090-6617
DOI
10.1155/2021/2361360
Publisher site
See Article on Publisher Site

Abstract

Hindawi Case Reports in Immunology Volume 2021, Article ID 2361360, 1 page https://doi.org/10.1155/2021/2361360 Erratum Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome” 1 2 Cesar Daniel Alonso-Bello , Marı´a del Carmen Jime´nez-Martı´nez , 1 3 Marı´a Eugenia Vargas-Camaño, Sagrario Hierro-Orozco, 4 5 6 Mario Alberto Ynga-Durand , Laura Berro´n-Ruiz, Julio Ce´sar Alca´ntara-Montiel, 6 1 1 Leopoldo Santos-Argumedo, Diana Andrea Herrera-Sa´nchez, Fernando Lozano-Patiño, and Marı´a Isabel Castrejo´n-Va´zquez Immunology and Allergy Department, Centro M´edico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico Faculty of Medicine, Universidad Nacional Auto´noma de M´exico, Mexico City, Mexico Dermatology Department, Centro M´edico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico Laboratorio de Inmunidad de Mucosas, Seccio´n de Investigacio´n y Posgrado, Escuela Superior de Medicina, Instituto Polit´ecnico Nacional, Mexico City, Mexico Immunodeficiencies Research Unit, Instituto Nacional de Pediatria, Secretar´ıa de Salud, Mexico City, Mexico Department of Molecular Biomedicine, CINVESTAV-IPN, Mexico City, Mexico Correspondence should be addressed to Cesar Daniel Alonso-Bello; cesar_alonso86@hotmail.com Received 27 October 2020; Accepted 27 October 2020; Published 12 February 2021 Copyright © 2021 Cesar Daniel Alonso-Bello et al. &is is an open access article distributed under the Creative Commons AttributionLicense, which permitsunrestricteduse, distribution, andreproductioninanymedium, providedthe originalworkis properly cited. In the article titled “Partial and Transient Clinical Response &e corrected list of affiliations is shown in the authors’ to Omalizumab in IL-21-Induced Low STAT3-Phosphor- information above. ylation on Hyper-IgE Syndrome” [1], authors Mario Alberto Ynga-Durand and Julio Ce´sar Alca´ntara-Montiel References were affiliated to “Universidad Nacional Auto´noma de [1] C. D. Alonso-Bello, M. d. C. Jimenez-Mart ´ ´ınez, M. E. Vargas- Mexico, Facultad de Estudios Superiores Zaragoza, Fac- Camaño et al., “Partial and Transient Clinical Response to ultad de Medicina, Mexico,” which is incorrect. Omalizumab in IL-21-Induced Low STAT3-Phosphorylation &e correct affiliation of Mario Alberto Ynga-Durand is on Hyper-IgE Syndrome,” Case Reports in Immunology, “Laboratorio de Inmunidad de Mucosas, Seccion de Inves- vol. 2019, Article ID 6357256, 5 pages, 2019. tigacio´n y Posgrado, Escuela Superior de Medicina, Instituto Polite´cnico Nacional, Mexico City, Mexico.” &e correct af- filiation for Julio Ce´sar Alca´ntara-Montiel is “Department of Molecular Biomedicine, CINVESTAV-IPN, Mexico City, Mexico.” &e error was introduced during the production process of the article, and Hindawi apologises for causing this error in the article.

Journal

Case Reports in ImmunologyHindawi Publishing Corporation

Published: Feb 12, 2021

References